T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Cintas
CTAS
$80.3B
| $274M | 0.04% |
5,533,220
-2,320,936
| -30% | -$120M |
|
402
Mattel
MAT
$4.25B
| $273M | 0.04% |
17,407,861
-1,341,460
| -7% | -$21.5M |
|
|
PDCO
403
DELISTED
Patterson Companies, Inc.
PDCO
| $273M | 0.04% |
11,168,558
+467,090
| +4% | +$11.1M |
|
|
XLRN
404
DELISTED
Acceleron Pharma
XLRN
| $272M | 0.04% |
4,760,028
+469,236
| +11% | +$23.1M |
|
|
GRFS
405
Grifois
GRFS
$5.4B
| $272M | 0.04% |
12,740,469
-5,874,606
| -32% | -$124M |
|
406
Landstar System
LSTR
$6.4B
| $272M | 0.04% |
2,226,974
-66,373
| -3% | -$7.68M |
|
407
3M
MMM
$94.2B
| $271M | 0.04% |
1,538,976
-32,920
| -2% | -$5.67M |
|
408
Ameriprise Financial
AMP
$50.4B
| $270M | 0.04% |
1,825,723
+1,037,111
| +132% | +$148M |
|
|
WUBA
409
DELISTED
58.com Inc
WUBA
| $266M | 0.04% |
3,612,590
+88,441
| +3% | +$6.11M |
|
|
AAN.A
410
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $266M | 0.04% |
4,878,951
+1,484,048
| +44% | +$80.8M |
|
|
RTN
411
DELISTED
Raytheon Company
RTN
| $266M | 0.04% |
1,285,456
+156,113
| +14% | +$31.1M |
|
|
SEE
412
DELISTED
Sealed Air
SEE
| $263M | 0.04% |
6,549,157
+1,320,505
| +25% | +$54.6M |
|
413
Darden Restaurants
DRI
$25.4B
| $263M | 0.04% |
2,362,036
-200,029
| -8% | -$22.5M |
|
|
IMMU
414
DELISTED
Immunomedics Inc
IMMU
| $262M | 0.04% |
12,588,635
+3,818,816
| +44% | +$90.5M |
|
415
Lear
LEA
$8.16B
| $259M | 0.04% |
1,788,777
+1,756,820
| +5,497% | +$301M |
|
416
Xencor
XNCR
$1.71B
| $259M | 0.04% |
6,635,630
+350,168
| +6% | +$14.3M |
|
417
Expedia Group
EXPE
$39.4B
| $258M | 0.04% |
1,977,913
-1,578,332
| -44% | -$205M |
|
418
Edgewell Personal Care
EPC
$1.31B
| $257M | 0.04% |
5,558,766
-94,148
| -2% | -$4.98M |
|
419
Lennox International
LII
$14.5B
| $255M | 0.04% |
1,167,259
-412,300
| -26% | -$89.8M |
|
420
Bankunited
BKU
$3.41B
| $251M | 0.04% |
7,101,369
-152,006
| -2% | -$5.99M |
|
421
Sun Life Financial
SLF
$44.8B
| $251M | 0.04% |
6,325,775
+748,511
| +13% | +$30M |
|
422
Macerich
MAC
$6.99B
| $251M | 0.04% |
4,543,836
+77,053
| +2% | +$4.44M |
|
|
VIAB
423
DELISTED
Viacom Inc. Class B
VIAB
| $251M | 0.04% |
7,428,007
+14,004
| +0.2% | +$420K |
|
424
Armstrong World Industries
AWI
$7.68B
| $248M | 0.04% |
3,570,385
+4,897
| +0.1% | +$338K |
|
425
Old Dominion Freight Line
ODFL
$44.7B
| $246M | 0.04% |
4,581,639
-89,214
| -2% | -$4.52M |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.